Back to results

Active, not recruitingPhase 2

Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy

NCT06671938

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Centrum Medyczyne Neuromed Sp. z o.o.

Bydgoszcz, Poland

+6 additional locations

View on ClinicalTrials.gov

Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy — TrialFind